Login
Login     |     Register     |     Recover Username/Password

General Investing

U.S. Global Investors (GROW) Trades Inexpensively Relative to Assets

April 02, 2013

U.S. Global Investors (GROW) trades inexpensively relative to the assets the company holds. This mutual fund firm, managed entrepreneurialy by CEO Frank Holmes, specializes in gold, natural resources and emerging market investing, and it is currently investing in smaller-cap companies where much of the appreciation should take place in the next decade, says Paul Sutherland, President of Financial & Investment Management Group.

“[GROW] basically has around $30 million of cash and investments on the balance sheet, and the whole market cap of the company is $58 million. They also own a piece of real estate. So the company is bargain priced, plus you’re getting $1.6 billion of assets under management — maybe it’s little bit less than that as gold stocks have had a rough go in 2013. It’s almost like the market’s saying that this company’s going to lose a half or two-thirds of its assets, and so it’s a very bargain-price asset,” Sutherland said.

FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.

Sutherland says the dividend decrease inordinately affected GROW‘s stock price, leading to a market depreciation which did not take into account the true fundamental value of the company.

“Another reason the stocks got cheap lately is they cut their dividend and decided to buy back shares instead of paying a significant dividend. So I think a lot of investors that owned this because they got a nice dividend sold it because they weren’t getting the dividend, and probably didn’t look under the covers to see whether there was a rational reason for that. I’ve met Frank Holmes, I’ve met his team. They’re good guys, they’re craftsmen, they love managing money,” Sutherland said.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now